Many of us would say that 2021 was a challenging year. For Trajan though it was marked by a successful IPO on the ASX in June, followed by several acquisitions and equity investments.
Trajan Scientific and Medical has finalized the acquisition of the latest addition to their portfolio, Axel Semrau GmbH & Co expanding its capabilities in the automation, chromatography, and so...
Trajan Scientific and Medical has successfully completed a 3-year ISO 9001:2015 recertification at our Ringwood global headquarters this week, cementing the importance that we place over quality ma...
Global analytical science and device company Trajan Group Holdings Limited (Trajan or the Company) has launched a $90 million IPO to support the next phase of acce...
Trajan Scientific and Medical (Trajan) has completed the acquisition of the MyHealthTest b...
Trajan Scientific and Medical’s (Trajan) highly successful ASTech1 program has resulted in the commercial development of several new syringe technologies. The program was developed in collaboration...
In 2017 the joint venture between Trajan Scientific and Medical (Trajan) and leading experts in the field of nutrition, Professors Maria Makrides and Robert Gibson was established as Trajan Nutriti...